Quick Answer
TREACE MEDICAL CONCEPTS, INC. reported Gross Profit of $169.75 million for fiscal year 2025.
TREACE MEDICAL CONCEPTS, INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $169.75M | +0.9% |
| 2024 | $168.26M | +10.7% |
| 2023 | $151.94M | +30.6% |
| 2022 | $116.31M | +50.0% |
| 2021 | $77.53M | +72.7% |
| 2020 | $44.90M | +41.2% |
| 2019 | $31.79M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $39.71M | +9.9% | +5.2% |
| June 30, 2025 | $37.75M | +5.8% | -9.9% |
| March 31, 2025 | $41.89M | +2.2% | +15.9% |
| September 30, 2024 | $36.13M | +10.3% | +1.3% |
| June 30, 2024 | $35.67M | +4.1% | -12.9% |
| March 31, 2024 | $40.98M | +20.0% | +25.1% |
| September 30, 2023 | $32.76M | +21.5% | -4.4% |
| June 30, 2023 | $34.28M | +38.9% | +0.4% |
- TREACE MEDICAL CONCEPTS, INC. showed an increase of +0.9% in Gross Profit compared to the prior fiscal year.
- Over the 2019–2025 period, TREACE MEDICAL CONCEPTS, INC.’s gross profit has grown by 434.1% (from $31.79 million to $169.75 million).
- The most recent figure is from TREACE MEDICAL CONCEPTS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: